Variant report

Variant	nsv1061709
Chromosome Location	chr16:82093183-82159867
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:632)
CpG islands
(count:366)
Chromatin interactive
region (count:49)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:632 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:82115933-82117726	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:82093606-82093975	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:82113187-82113930	HepG2	liver:	n/a	n/a
4	ARID3A	chr16:82155008-82155157	K562	blood:	n/a	n/a
5	ARID3A	chr16:82101178-82101501	HepG2	liver:	n/a	n/a
6	ARID3A	chr16:82095460-82096457	HepG2	liver:	n/a	n/a
7	ATF1	chr16:82153837-82154037	K562	blood:	n/a	n/a
8	ATF1	chr16:82114661-82114765	K562	blood:	n/a	n/a
9	ATF1	chr16:82104326-82104461	K562	blood:	n/a	n/a
10	ATF1	chr16:82096406-82096697	K562	blood:	n/a	n/a
11	ATF1	chr16:82112112-82112365	K562	blood:	n/a	n/a
12	ATF1	chr16:82138925-82138954	K562	blood:	n/a	n/a
13	BACH1	chr16:82104509-82105032	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr16:82137189-82137191	K562	blood:	n/a	n/a
15	BATF	chr16:82116361-82116774	GM12878	blood:	n/a	chr16:82116546-82116557
16	BATF	chr16:82142916-82143193	GM12878	blood:	n/a	n/a
17	BATF	chr16:82116362-82116724	GM12878	blood:	n/a	chr16:82116546-82116557
18	BCLAF1	chr16:82116435-82116713	GM12878	blood:	n/a	n/a
19	BHLHE40	chr16:82115821-82115866	K562	blood:	n/a	n/a
20	BHLHE40	chr16:82116388-82116902	HepG2	liver:	n/a	n/a
21	BHLHE40	chr16:82113873-82113886	HepG2	liver:	n/a	n/a
22	CEBPB	chr16:82095533-82095900	A549	lung:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
23	CEBPB	chr16:82096233-82096438	HepG2	liver:	n/a	n/a
24	CEBPB	chr16:82093627-82093972	HepG2	liver:	n/a	chr16:82093779-82093796
25	CEBPB	chr16:82095229-82095863	IMR90	lung:	n/a	chr16:82095329-82095342 chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095329-82095342 chr16:82095329-82095342 chr16:82095717-82095728 chr16:82095329-82095340 chr16:82095329-82095340
26	CEBPB	chr16:82095471-82096019	MCF-7	breast:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
27	CEBPB	chr16:82136694-82136852	A549	lung:	n/a	n/a
28	CEBPB	chr16:82117643-82117982	HepG2	liver:	n/a	chr16:82117810-82117821
29	CEBPB	chr16:82096173-82096695	HepG2	liver:	n/a	n/a
30	CEBPB	chr16:82095504-82095901	A549	lung:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
31	CEBPB	chr16:82093688-82093868	HepG2	liver:	n/a	chr16:82093779-82093796
32	CEBPB	chr16:82095497-82095891	K562	blood:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
33	CEBPB	chr16:82096154-82096636	HepG2	liver:	n/a	n/a
34	CEBPB	chr16:82122160-82122358	K562	blood:	n/a	n/a
35	CEBPB	chr16:82096280-82096396	K562	blood:	n/a	n/a
36	CEBPB	chr16:82095538-82095898	H1-hESC	embryonic stem cell:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
37	CEBPB	chr16:82095444-82095983	A549	lung:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
38	CEBPB	chr16:82096155-82096549	HepG2	liver:	n/a	n/a
39	CEBPB	chr16:82093578-82094008	HepG2	liver:	n/a	chr16:82093779-82093796
40	CEBPB	chr16:82113635-82114071	HepG2	liver:	n/a	n/a
41	CEBPB	chr16:82097282-82097393	HepG2	liver:	n/a	n/a
42	CEBPB	chr16:82136600-82136860	HepG2	liver:	n/a	n/a
43	CEBPB	chr16:82095327-82095883	Hela-S3	cervix:	n/a	chr16:82095329-82095342 chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095329-82095342 chr16:82095329-82095342 chr16:82095717-82095728 chr16:82095329-82095340 chr16:82095329-82095340
44	CEBPB	chr16:82122122-82122287	HepG2	liver:	n/a	n/a
45	CEBPB	chr16:82145685-82146347	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr16:82116485-82116607	HepG2	liver:	n/a	n/a
47	CEBPB	chr16:82116406-82116778	HepG2	liver:	n/a	n/a
48	CEBPB	chr16:82095440-82095929	MCF-7	breast:	n/a	chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095717-82095728
49	CEBPB	chr16:82095133-82095904	K562	blood:	n/a	chr16:82095329-82095342 chr16:82095715-82095728 chr16:82095717-82095726 chr16:82095329-82095342 chr16:82095329-82095342 chr16:82095717-82095728 chr16:82095329-82095340 chr16:82095329-82095340
50	CEBPB	chr16:82100670-82101146	IMR90	lung:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:82132065-82132115	T-47D	breast:	n/a
2	chr16:82117013-82117063	PFSK-1	brain:	n/a
3	chr16:82132065-82132115	PFSK-1	brain:	n/a
4	chr16:82129088-82129138	HCPEpiC	choroid plexus:	n/a
5	chr16:82096597-82096647	AG09319	gingival:	n/a
6	chr16:82117013-82117063	BJ	skin:	n/a
7	chr16:82132065-82132115	HCPEpiC	choroid plexus:	n/a
8	chr16:82117013-82117063	HPAEpiC	pulmonary alveolar:	n/a
9	chr16:82126267-82126317	HCM	heart:	n/a
10	chr16:82096597-82096647	MCF10A-Er-Src	breast:	n/a
11	chr16:82126267-82126317	NHBE	bronchial:	n/a
12	chr16:82126267-82126317	SKMC	muscle:	n/a
13	chr16:82126267-82126317	AoSMC	blood vessel:	n/a
14	chr16:82117013-82117063	GM06990	blood:	n/a
15	chr16:82126267-82126317	SK-N-SH_RA	brain:	n/a
16	chr16:82132065-82132115	AG04450	lung:	fetal
17	chr16:82096597-82096647	ProgFib	skin:	n/a
18	chr16:82104638-82104688	NT2-D1	testis:	n/a
19	chr16:82129088-82129138	HRCEpiC	kidney:	n/a
20	chr16:82129088-82129138	GM12892	blood:	n/a
21	chr16:82129088-82129138	HRE	kidney:	n/a
22	chr16:82096597-82096647	HRPEpiC	eye:	n/a
23	chr16:82117013-82117063	T-47D	breast:	n/a
24	chr16:82132065-82132115	HNPCEpiC	eye:	n/a
25	chr16:82132065-82132115	U87	brain:	n/a
26	chr16:82126267-82126317	AG04449	skin:	fetal
27	chr16:82132065-82132115	HEK293	kidney:	embryo
28	chr16:82096597-82096647	HAEpiC	amniotic membrane:	n/a
29	chr16:82104638-82104688	Caco-2	colon:	n/a
30	chr16:82132065-82132115	HEEpiC	esophagus:	n/a
31	chr16:82104638-82104688	PFSK-1	brain:	n/a
32	chr16:82129088-82129138	NHBE	bronchial:	n/a
33	chr16:82132065-82132115	IMR90	lung:	fetal
34	chr16:82132065-82132115	NB4	blood:	n/a
35	chr16:82126267-82126317	AG09309	skin:	n/a
36	chr16:82126267-82126317	HEEpiC	esophagus:	n/a
37	chr16:82117013-82117063	HEK293	kidney:	embryo
38	chr16:82104638-82104688	HUVEC	blood vessel:	n/a
39	chr16:82104638-82104688	HCPEpiC	choroid plexus:	n/a
40	chr16:82132065-82132115	Jurkat	blood:	n/a
41	chr16:82104638-82104688	SK-N-MC	brain:	n/a
42	chr16:82096597-82096647	NB4	blood:	n/a
43	chr16:82117013-82117063	HepG2	liver:	n/a
44	chr16:82117013-82117063	BE2_C	brain:	n/a
45	chr16:82117013-82117063	AG09309	skin:	n/a
46	chr16:82117013-82117063	LNCaP	prostate:	n/a
47	chr16:82096597-82096647	H1-hESC	embryonic stem cell:	embryo
48	chr16:82132065-82132115	K562	blood:	n/a
49	chr16:82132065-82132115	A549	lung:	n/a
50	chr16:82126267-82126317	SK-N-MC	brain:	n/a

(count:49 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:82119460..82121680-chr16:82123785..82126010,2	MCF-7	breast:
2	chr16:82135638..82136440-chr16:82263371..82264096,2	MCF-7	breast:
3	chr16:82113332..82114917-chr16:82118143..82120732,2	MCF-7	breast:
4	chr16:82125995..82128874-chr16:82143383..82145730,2	MCF-7	breast:
5	chr16:82123378..82125016-chr16:82127857..82130334,2	K562	blood:
6	chr16:82104757..82105690-chr16:82117301..82118203,5	MCF-7	breast:
7	chr16:82117481..82118176-chr16:82170571..82171399,4	MCF-7	breast:
8	chr16:82064842..82065598-chr16:82095362..82096218,4	MCF-7	breast:
9	chr16:82094565..82097297-chr16:82099404..82102388,2	K562	blood:
10	chr16:82117283..82118187-chr16:82171594..82172375,3	MCF-7	breast:
11	chr16:82117212..82118185-chr16:82169847..82171525,14	MCF-7	breast:
12	chr16:82093387..82094131-chr16:82117369..82118164,3	MCF-7	breast:
13	chr16:82094565..82097297-chr16:82099404..82102388,2	K562	blood:
14	chr16:82137826..82139962-chr16:82141084..82143909,2	K562	blood:
15	chr16:82093387..82094131-chr16:82117369..82118164,3	MCF-7	breast:
16	chr16:81972421..81973396-chr16:82117292..82118076,5	MCF-7	breast:
17	chr16:82089033..82091508-chr16:82094074..82095651,2	K562	blood:
18	chr16:82095196..82096036-chr16:82263712..82264246,2	MCF-7	breast:
19	chr16:82117219..82118195-chr16:82138911..82139841,2	MCF-7	breast:
20	chr16:82148823..82151078-chr16:82169723..82171440,2	K562	blood:
21	chr16:81974221..81975055-chr16:82095227..82096139,4	MCF-7	breast:
22	chr16:82127698..82130155-chr16:82130878..82132469,2	MCF-7	breast:
23	chr16:82119460..82121680-chr16:82123785..82126010,2	MCF-7	breast:
24	chr16:81974410..81975126-chr16:82095007..82095937,2	MCF-7	breast:
25	chr16:82115526..82118305-chr16:82123989..82125939,2	K562	blood:
26	chr16:82113332..82114917-chr16:82118143..82120732,2	MCF-7	breast:
27	chr16:82117593..82118221-chr16:82186289..82186795,2	MCF-7	breast:
28	chr16:82117219..82118195-chr16:82138911..82139841,3	MCF-7	breast:
29	chr16:82117260..82118221-chr16:82185963..82186837,6	MCF-7	breast:
30	chr16:82123378..82125016-chr16:82127857..82130334,2	K562	blood:
31	chr16:82111015..82113316-chr16:82120148..82122366,2	MCF-7	breast:
32	chr16:82069797..82071329-chr16:82092897..82095086,2	MCF-7	breast:
33	chr16:82122956..82125901-chr16:82268346..82271123,2	K562	blood:
34	chr16:82153037..82154968-chr16:82160886..82163230,2	MCF-7	breast:
35	chr16:82138879..82139474-chr16:82170604..82171398,2	MCF-7	breast:
36	chr16:82117219..82118195-chr16:82138911..82139841,3	MCF-7	breast:
37	chr16:82137826..82139962-chr16:82141084..82143909,2	K562	blood:
38	chr16:82127698..82130155-chr16:82130878..82132469,2	MCF-7	breast:
39	chr16:81923547..81924618-chr16:82095228..82096136,4	K562	blood:
40	chr16:82115526..82118305-chr16:82123989..82125939,2	K562	blood:
41	chr16:81972807..81973396-chr16:82117292..82117826,2	MCF-7	breast:
42	chr16:82104757..82105690-chr16:82117301..82118203,5	MCF-7	breast:
43	chr16:82123385..82125267-chr16:82203354..82206097,2	K562	blood:
44	chr16:82111015..82113316-chr16:82120148..82122366,2	MCF-7	breast:
45	chr16:82104751..82105655-chr16:82170497..82171564,4	MCF-7	breast:
46	chr16:81974156..81975014-chr16:82095141..82095762,2	K562	blood:
47	chr16:82117219..82118195-chr16:82138911..82139841,2	MCF-7	breast:
48	chr16:82117334..82118246-chr16:82170586..82171478,6	MCF-7	breast:
49	chr16:64240204..64240760-chr16:82095477..82096225,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SDR42E1-1	chr16:82096698-82096858	ENSG00000261235.1
2	lnc-SDR42E1-1	chr16:82096698-82096827	ENSG00000261235.1
3	lnc-SDR42E1-1	chr16:82104408-82104794	ENSG00000261235.1

No data

Variant related genes	Relation type
HSD17B2	TF binding region
ENSG00000263636	TF binding region
ENSG00000260161	TF binding region
ENSG00000261235	TF binding region
HSD17B2	CpG island
ENSG00000263636	CpG island
ENSG00000260161	CpG island
ENSG00000261235	CpG island
ENSG00000086696	chromatin interactions
ENSG00000261029	chromatin interactions
ENSG00000135698	chromatin interactions
ENSG00000263636	chromatin interactions
ENSG00000261235	chromatin interactions

Extended variants
information (count: 3627 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:3627 , 50 per page) page: 1 2 3 4 5 6 7 ... 73

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8191101	chr16:82093183-82093184	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs139163867	chr16:82093188-82093189	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs185248298	chr16:82093200-82093201	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs8191102	chr16:82093215-82093216	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs144104020	chr16:82093225-82093226	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs190437416	chr16:82093228-82093229	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs530805830	chr16:82093230-82093231	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs551901477	chr16:82093244-82093245	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs570387440	chr16:82093278-82093279	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs4497679	chr16:82093283-82093284	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs8191103	chr16:82093326-82093327	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs574076240	chr16:82093331-82093332	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs567809333	chr16:82093338-82093339	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs146444955	chr16:82093343-82093344	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs144569952	chr16:82093360-82093361	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs368847697	chr16:82093394-82093395	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs8191104	chr16:82093399-82093400	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs8191105	chr16:82093407-82093408	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs8191106	chr16:82093422-82093423	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs558681102	chr16:82093445-82093446	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs548992332	chr16:82093457-82093458	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs8191107	chr16:82093474-82093475	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs146677231	chr16:82093501-82093502	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs569115015	chr16:82093524-82093525	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs370476122	chr16:82093573-82093574	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs541426441	chr16:82093574-82093575	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs149006201	chr16:82093588-82093589	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs530195619	chr16:82093611-82093612	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs542068633	chr16:82093613-82093614	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs181941941	chr16:82093660-82093661	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs8191108	chr16:82093684-82093685	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs530724723	chr16:82093702-82093703	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs372585828	chr16:82093708-82093709	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs143833743	chr16:82093722-82093723	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs564222569	chr16:82093723-82093724	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs72829168	chr16:82093743-82093744	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs528118258	chr16:82093763-82093764	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs546176438	chr16:82093791-82093792	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs4453484	chr16:82093801-82093802	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs148136231	chr16:82093855-82093856	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs8191109	chr16:82093877-82093878	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs377091426	chr16:82093952-82093953	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs141927645	chr16:82093955-82093956	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs8191110	chr16:82093986-82093987	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs537243641	chr16:82094060-82094061	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs8191111	chr16:82094070-82094071	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs146818113	chr16:82094071-82094072	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs553058243	chr16:82094085-82094086	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs557889943	chr16:82094092-82094093	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs535046881	chr16:82094120-82094121	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Obesity	20622171	CNVD
Cancer	20164920	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16461572	CNVD

Chromatin state (count:499 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:82076600-82094800	Enhancers	Fetal Intestine Large	intestine
2	chr16:82086200-82103800	Weak transcription	Gastric	stomach
3	chr16:82089400-82093800	Weak transcription	Lung	lung
4	chr16:82089400-82105800	Weak transcription	Rectal Smooth Muscle	rectum
5	chr16:82089600-82103800	Weak transcription	Pancreas	Pancrea
6	chr16:82090000-82093400	Weak transcription	Primary neutrophils fromperipheralblood	blood
7	chr16:82090200-82093400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
8	chr16:82090600-82095400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr16:82090600-82095800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr16:82090600-82095800	Weak transcription	NHEK	skin
11	chr16:82090800-82101000	Enhancers	HepG2	liver
12	chr16:82091400-82093200	Weak transcription	HMEC	breast
13	chr16:82091400-82095000	Enhancers	Placenta	Placenta
14	chr16:82091600-82094000	Enhancers	Duodenum Mucosa	Duodenum
15	chr16:82092000-82093800	Enhancers	Small Intestine	intestine
16	chr16:82092000-82095000	Enhancers	Rectal Mucosa Donor 31	rectum
17	chr16:82092000-82096400	Enhancers	Fetal Intestine Small	intestine
18	chr16:82092200-82094200	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr16:82092200-82094200	Enhancers	Stomach Mucosa	stomach
20	chr16:82092400-82094400	Enhancers	NHDF-Ad	bronchial
21	chr16:82092400-82094400	Enhancers	NHLF	lung
22	chr16:82092600-82093200	Weak transcription	Colonic Mucosa	Colon
23	chr16:82092800-82093400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr16:82092800-82094000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr16:82092800-82094600	Enhancers	Rectal Mucosa Donor 29	rectum
26	chr16:82093000-82093200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr16:82093000-82093200	Bivalent Enhancer	HSMMtube	muscle
28	chr16:82093000-82093600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr16:82093000-82093600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr16:82093000-82093800	Weak transcription	Sigmoid Colon	Sigmoid Colon
31	chr16:82093000-82094600	Flanking Active TSS	Liver	Liver
32	chr16:82093200-82093400	Enhancers	Colonic Mucosa	Colon
33	chr16:82093200-82093800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr16:82093200-82093800	Enhancers	HMEC	breast
35	chr16:82093200-82094400	Enhancers	HSMMtube	muscle
36	chr16:82093400-82093800	Weak transcription	Colonic Mucosa	Colon
37	chr16:82093400-82094200	Enhancers	Primary neutrophils fromperipheralblood	blood
38	chr16:82093400-82094200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr16:82093400-82095400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
40	chr16:82093600-82093800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr16:82093600-82093800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr16:82093600-82094000	Bivalent Enhancer	HSMM	muscle
43	chr16:82093800-82094200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr16:82093800-82094400	Enhancers	Sigmoid Colon	Sigmoid Colon
45	chr16:82093800-82094600	Enhancers	Colonic Mucosa	Colon
46	chr16:82093800-82094600	Enhancers	Lung	lung
47	chr16:82093800-82095400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr16:82093800-82095400	Weak transcription	HMEC	breast
49	chr16:82093800-82095600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr16:82093800-82096000	Weak transcription	Small Intestine	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links